Irvine, California -- Medical device technology company AcuFocus has received $4 million in venture capital debt investment, according to an SEC regulatory filing.
AcuFocus has developed inlay technology designed specifically for presbyopia or near vision loss.
Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.
A total of 16 investors participated in the financing.
AcuFocus is still seeking $150,000 in additional debt investment, according to the filing.